Investment, Banking & Finance

9

Wealth Management

9

Foreign Investment Law

Family & Personal Law

9

Family & Personal Status Law

9

Wealth Management

9

Management & Foreign Citizenship

Real Estate & Property Law

9

Real Estate Legal Services

9

Property Disputes

9

Construction & Infrastructure Law

Government Services

9

Public-Private Partnerships (PPP)

9

Government Contracts (General Terms & Conditions)

9

Public Sector Procurement & Tendering

9

Letter of Award

Healthcare, Pharmaceutical, and Life Sciences

9

Healthcare & Pharmaceutical Law

9

Property Disputes

9

Medical Negligence

Energy, Environment, and Natural Resources Law

9

Energy, Oil & Gas Law

9

Environmental Law & Sustainability

SUBSCRIBE

8

Introduction to the 2026 R&D Tax Framework

The United Arab Emirates continues to strengthen its position as a global hub for innovation, investment, and advanced industries through the introduction of structured regulatory frameworks supporting research and development (R&D).

A recent Ministerial Decision issued in 2026 provides detailed guidance on the application of R&D tax incentives under the UAE Corporate Tax regime. This development represents a significant milestone in aligning the UAE’s tax framework with international standards while actively encouraging economic diversification and technological advancement.

Legislative Basis and Policy Objectives

The new regulations, issued pursuant to Federal Decree-Law No. 47 of 2022 on the Taxation of Corporations and Businesses, establish clear conditions under which businesses can benefit from R&D-related tax relief.

The framework reflects the UAE’s broader policy objective of fostering innovation-driven growth by providing financial incentives to entities engaged in scientific, technological, and experimental development activities.

At its core, the regime aims to ensure that only genuine R&D activities—those involving systematic investigation and innovation—qualify for tax benefits.

Defining Qualifying R&D Activities

A key aspect of the Decision is the definition and scope of qualifying R&D activities. The law distinguishes between routine or commercial activities and genuine research-driven initiatives.

To qualify, activities must be directed toward achieving scientific or technological advancement and must involve uncertainty, experimentation, and the creation of new knowledge or improvements.

Routine adaptations, market research, or standard commercial operations do not fall within the scope of eligible activities. This distinction is critical for businesses seeking to rely on these incentives, as improper classification may lead to the disallowance of tax benefits.

Methodology for Calculating R&D Expenditure

The regulations introduce a structured methodology for calculating qualifying R&D expenditure. Businesses may claim relief based on actual expenditure incurred in relation to R&D activities, subject to specific thresholds and documentation requirements.

The framework outlines a tiered system where varying percentages of qualifying expenditure may be eligible depending on the scale and nature of the activity. This structured approach ensures consistency and transparency while preventing misuse of the system.

Emphasis on Substance and Documentation

A critical element of the new framework is the emphasis on substance and documentation. Businesses must maintain detailed records demonstrating that the claimed activities meet the legal criteria for R&D.

This includes:

  • Technical documentation
  • Project reports
  • Financial records
  • Evidence of scientific or technological uncertainty

Failure to maintain adequate documentation may result in the rejection of claims during tax audits or regulatory reviews.

Treatment of Group Structures and Partnerships

The Decision addresses the treatment of R&D activities conducted through partnerships, group structures, or outsourced arrangements.

The allocation of R&D expenditure must reflect the actual economic substance and contribution of each entity involved. This is particularly relevant for multinational corporations operating in the UAE, where R&D functions may be distributed across multiple jurisdictions.

The regulations aim to prevent artificial allocation of expenses while ensuring that legitimate activities conducted within the UAE are appropriately incentivized.

Limitations, Exclusions, and Safeguards

The framework introduces limitations and exclusions designed to safeguard the integrity of the tax system.

Excluded expenditures include:

  • Non-scientific administrative costs
  • Marketing expenses
  • Activities lacking genuine innovation

Additionally, the Decision prevents double counting of expenses and ensures that incentives align with actual economic activity. These safeguards are consistent with international best practices, particularly those recommended by the OECD in relation to Base Erosion and Profit Shifting (BEPS).

Compliance Standards and Strategic Opportunities

From a compliance perspective, the new rules impose a higher standard of scrutiny on businesses seeking to benefit from R&D incentives.

Entities must:

  • Assess whether their activities genuinely qualify
  • Enhance internal documentation processes
  • Coordinate between legal, financial, and technical teams

Failure to comply may result in audit challenges, penalties, or denial of tax benefits.

From a strategic standpoint, the framework presents a valuable opportunity. Businesses in sectors such as:

  • Technology
  • Manufacturing
  • Pharmaceuticals
  • Artificial Intelligence

stand to benefit significantly. The framework encourages investment in local R&D capabilities, strengthening the UAE’s position as a knowledge-based economy and enhancing its attractiveness to foreign investors.

Strategic Conclusion and Expert Support

This development represents a forward-looking initiative aligning the UAE with leading global economies in promoting research and innovation. However, the complexity of the regulatory framework requires careful legal and tax analysis.

Businesses must identify qualifying activities while ensuring full compliance with documentation, reporting, and substance requirements.

In conclusion, the UAE’s R&D tax incentive framework marks a significant evolution in the corporate tax landscape. While it offers substantial opportunities, it also introduces regulatory complexity that necessitates expert guidance.

Companies operating in or entering the UAE market should proactively assess eligibility and implement robust compliance measures to maximize benefits.

For legal and regulatory advice on R&D tax incentives, corporate structuring, and UAE Corporate Tax compliance, KH Legal remains available to provide comprehensive and strategic support.

Frequently Asked Questions (FAQ)

1. What qualifies as an R&D activity under the new UAE tax rules?
Activities must involve systematic investigation aimed at achieving scientific or technological advancement, including elements of uncertainty, experimentation, and the creation of new knowledge.

2. Are routine commercial operations eligible for R&D tax incentives?
No. Routine adaptations, market research, and standard commercial operations are excluded from eligibility.

3. What types of expenses are excluded from R&D tax relief?
Non-scientific administrative costs, marketing expenses, and activities lacking genuine innovation are excluded.

4. How is R&D expenditure calculated for tax relief?
Relief is based on actual expenditure using a tiered system, where eligibility depends on the scale and nature of the R&D activity.

5. What documentation must a business maintain for an R&D claim?
Businesses must maintain detailed technical reports, financial records, and evidence demonstrating the scientific or technological uncertainty addressed.

If you require further clarification or legal assistance concerning the matters discussed in this article, please do not hesitate to contact Khairallah Advocates & Legal Consultants LLC. Our lawyers would be happy to assist you.

Authors:

Lawyer card                Lawyer card